4Parkins MD, Gregson DB, Pitout JD, et al. Population- Based Study of the Epidemlology and the Risk Factors for Pseudomonas aeruginosa Bloodstream Infection[J]. Infection,2010,38(1):25-32.
5Trecarichi EM, Tumbarello M, Caira M, et al. Muhidrug resistant Pseudomonas aeruginosa bloodstream infection in adult patients with hematologic malignancies[J]. Haematologiea, 2011,96(1):e1-3.
6Thong KL, Lai MY, Teh C SJ, et al. Simultaneous detection of methicillin-resistant Staphylococcus aureus, Acinetobacter baumannii, Escherichia coli, Klebsiella pneumoniae and Psendomonas aeruginosa by muhiplex PCR [ J ] . Trop Biomed, 2011, 28 ( 1 ) : 21-31.
7Uslan DZ, Crane SJ, Steckelberg JM, et al. Age- and sex-associated trends in bloodstream infection : a population-based study in Olmsted County, Minnesota [ J ] . Arch Intern Med, 2007, 167 ( 8 ) : 834- 839.
8Mar t n M, Gudiol C, Garcia-Vidal C, et al. Bloodstream infections in patients with solid tumors : epidemiology, antibiotic therapy, and outcomes in 528 episodes in a single cancer center [ J ]. Medicine ( Baltimore ) , 2014, 93 ( 3 ) : 143-149.
9Hirsch EB, Cottreau JM, Chang KT, et al. A model to predict mortality following Pseudomonas aeruginosa haeteremia [ J ] . Diagn Microbiol Infect Dis, 2012, 72 ( 1 ) : 97-102.
10Kang CI, Kim SH, Kim HB, et al. Pseudomonas aeruginosa baeteremia : risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome [ J ] . Clin Infect Dis, 2003, 37 ( 6 ) : 745-751.
